Sky Pharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Sky Pharma General Information

Description

Operator of a pharmaceutical company intended to engage in the research and development of drugs. The company aims to commercialize regenerative medicine using low molecular weight compounds to mass-produce drugs at a lower cost than biopharmaceuticals that use induced pluripotent stem cells, providing patients with affordable medicinal alternatives for diseases and injuries for which complete recovery is considered difficult.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1Floor, Higashi Nippon Real Estate Sendai First Building
  • 6-1 Shimizu-koji, Wakabayashi-ku
  • Sendai, Miyagi 984-0075
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1Floor, Higashi Nippon Real Estate Sendai First Building
  • 6-1 Shimizu-koji, Wakabayashi-ku
  • Sendai, Miyagi 984-0075
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sky Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-May-2025 Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Accelerator/Incubator 19-Jun-2024 Completed Generating Revenue
2. Accelerator/Incubator 11-Oct-2021 $286K Completed Generating Revenue
1. Seed Round 08-Nov-2020 $286K $286K Completed Generating Revenue
To view Sky Pharma’s complete valuation and funding history, request access »

Sky Pharma Patents

Sky Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026020249-A Method for screening active pharmaceutical ingredient using function of cell or tissue as index Pending 31-Mar-2020
AU-2021250052-A1 Method for screening for, method for producing, and method for designing drug active ingredients Inactive 31-Mar-2020
CA-3178684-A1 Method for screening for, method for producing, and method for designing drug active ingredients Pending 31-Mar-2020
EP-4129339-A1 Method for screening for, method for producing, and method for designing drug active ingredients Pending 31-Mar-2020
EP-4129339-A4 Method for screening for, method for producing, and method for designing drug active ingredients Pending 31-Mar-2020 G01N33/15
To view Sky Pharma’s complete patent history, request access »

Sky Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sky Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
Digital Search and Advertising Corporation Minority
Minato Mirai Capital Venture Capital Minority
Spurcle Venture Capital Minority
To view Sky Pharma’s complete investors history, request access »

Sky Pharma FAQs

  • When was Sky Pharma founded?

    Sky Pharma was founded in 2019.

  • Where is Sky Pharma headquartered?

    Sky Pharma is headquartered in Sendai, Japan.

  • What is the size of Sky Pharma?

    Sky Pharma has 1 total employees.

  • What industry is Sky Pharma in?

    Sky Pharma’s primary industry is Drug Discovery.

  • Is Sky Pharma a private or public company?

    Sky Pharma is a Private company.

  • What is Sky Pharma’s current revenue?

    The current revenue for Sky Pharma is .

  • How much funding has Sky Pharma raised over time?

    Sky Pharma has raised $286K.

  • Who are Sky Pharma’s investors?

    Plug and Play, Digital Search and Advertising, Minato Mirai Capital, and Spurcle have invested in Sky Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process